Evidence map›Paper›PMID 41873289›Full record

ArticleCureus2026

Lung Function Impairment and Its Associated Factors in Pulmonary Tuberculosis Patients Upon Treatment Completion in Madurai District, Tamil Nadu: A Cross-Sectional Study.

Pooranagangadevi Navaneethapandian, Prabhakaran S Sarma, Mahalakshmi Rajendran, Kavumpurathu R Thankappan

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pooranagangadevi NavaneethapandianPublic Health, Amrita Institute of Medical Sciences, Kochi, IND.
Prabhakaran S SarmaPublic Health, Amrita Institute of Medical Sciences, Kochi, IND.
Mahalakshmi RajendranStatistics, Indian Council of Medical Research-National Institute for Research in Tuberculosis, Chennai, IND.
Kavumpurathu R ThankappanPublic Health, Amrita Institute of Medical Sciences, Kochi, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background While effective anti-tuberculosis treatment (ATT) has led to significant reductions in mortality, concerns persist about the potential for persistent lung damage and impaired pulmonary function among survivors. Data on the prevalence and predictors of lung function impairment (LFI) in post-TB patients in Tamil Nadu are limited. This study aims to evaluate the extent of LFI in pulmonary tuberculosis (PTB) patients upon treatment completion. Methods A cross-sectional analytical study was conducted among 132 adult patients aged 18 years and above diagnosed with PTB registered in the government National TB Elimination Program (NTEP) centres, in Madurai district, Tamil Nadu, with smear negative status at completion of standard ATT. Information was obtained on personal habits, respiratory symptoms and co-morbid conditions. A pulmonary function test was done using spirometry. Multiple binary logistic regression analysis was done to find the factors associated with LFI. Results Among the patients, 78 (59%; 95% CI (51% to 67%)) showed LFI. The most common abnormality identified was the restrictive pattern, seen in 72 individuals (55%). Patients with a previous history of anti-tuberculosis treatment (adjusted odds ratio (AOR) 2.4; 95% CI 1.0-5.7; p =0.034)), bilateral lung infiltrates (AOR 7.9; 95% CI: 2.7-23.3; p < 0.001), and ≥4 chest X-ray zones (AOR 11.1 CI 2.9-42.3; p <0.001) were more likely to have LFI. Conclusion LFI is highly prevalent among PTB patients after treatment completion, with previous TB episodes, radiological severity, and bilateral infiltrates being strong predictors. These findings underscore the necessity of post-treatment pulmonary surveillance, spirometry, and pulmonary rehabilitation to be integrated into TB care frameworks in this population.

Indexed as

lung function impairmentpulmonary function after tuberculosispulmonary function testpulmonary tuberculosis sequelaespirometry

Identifiers

PMID41873289
PMCPMC13005910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.